Trial Site Detail

 

Drug:
CB-839
Trial:
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors
Conditions: Solid Tumors
Trial Status:
Active, not recruiting

 

University of Pennsylvania

     
Philadelphia , PA 19104
USA

 

Principal Investigator:
 Angela M. DiMichele, MD
Contact:
 Jessica Burrell 215-662-2150 Jessica.Burrell@uphs.upenn.edu
Activation Status of this Site:
 Closed
Notes about this Site:
University of Pennsylvania Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.